RNU12-2P and systemic sclerosis: Compared with other known autoantibodies such as anti-RNAP3 and ACA, it emerged that both patients with anti-RNAP3 and anti-U11/U12 RNP present a mean age of SSc onset above 50 years and a shorter time to presentation for clinical evaluation than other antibody subgroups [169].